tolerated

Intrasal covid vaccine Bharat Biotech gets a nod for Phase II / III trials

Hyderabad: Candidates for Intra-Nasal Vaksin Covid-19 First India BBV154, which is being developed by Bharat Biotech along with the University…

3 years ago